Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

6 Stocks To Watch: AMD, CRON, CRSP, IOVA, PRVB, SOLY

Published 06/11/2019, 01:39 AM
Updated 07/09/2023, 06:31 AM

Advanced Micro Devices, Inc. (AMD)

Advanced Micro Devices, Inc. (NASDAQ:AMD) was ready to break out around the 28-29 area, I said your target is 33-34. It was up 82 cents, or 2.5%, to 33.23, on 98 million shares on Monday, and reached a high of 34.30. The next target is 36 3/4 and 40.

Cronos Group Inc. (CRON)

Cronos Group Inc (NASDAQ:CRON), (TSX:CRON) jumped 1.45, or 8%, to 17.39, on 9.6 million shares on Monday. I put a new swing on it on Monday because it went through the 50-day moving average and decline topsline. If it will follow through at 17.70, or thereabouts, then I’m looking for 19, 22, and 25.

CRISPR Therapeutics AG (CRSP)

Crispr Therapeutics AG (NASDAQ:CRSP) a swing trade of ours, is looking good. It gained 1.50, or 3.5%, to 44.38, on 1 million shares. I like the look here. I think it came through the neckline of the inverse head-and-shoulders on Monday. There’s a little resistance at 471/4-1/2, but if it gets through there, 54 is the next target.

Iovance Biotherapeutics, Inc. (IOVA)

Iovance Biotherapeutics Inc (NASDAQ:IOVA) had a beautiful follow-through on Monday, up another 82 cents, or 4.4%, to 19.93, on 2.8 million shares, and reached a high of 20.75. That’s a new, multi-year high for this stock, going all the way back 2013. That’s a new 6-year high. It might accelerate. If it does, look for something in the mid-20’s.

Provention Bio, Inc. (PRVB)

Provention Bio Inc (NASDAQ:PRVB) exploded on Monday on major news, backed way off, and then came on again, closing up 9.44, or 217%, to 13.79, on 26 million shares. That’s huge. I don’t think it will get below the gap at 9.44, and I’m looking for support at 9.75, 10, a retest at 18, 23, and then we’ll see what’s next.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Soliton, Inc. (SOLY)

Soliton Inc (NASDAQ:SOLY) may be coming out of a falling wedge. It reversed Friday, followed through on Monday, and gained 1.70, or 10%, to 17.90, on a million shares. It looks like it needs more volume. My short-term target is 201/2, 22, and then we’ll see if it will get higher than that.

Stocks on the long side

Advanced Micro Devices, Inc. (AMD), Amyris, Inc. (AMRS), Beyond Meat, Inc. (BYND), Cronos Group Inc. (CRON), CRISPR Therapeutics AG (CRSP), Corindus Vascular Robotics, Inc. (CVRS), Daqo New Energy Corp. (DQ), Endologix, Inc. (ELGX), Iovance Biotherapeutics, Inc. (IOVA), JinkoSolar Holding Co., Ltd. (JKS), Kodiak Sciences Inc. (KOD), PaySign, Inc. (PAYS), Provention Bio, Inc. (PRVB), Qudian Inc. (QD), Soliton, Inc. (SOLY), ShockWave Medical, Inc. (SWAV), Upland Software, Inc. (UPLD), USA Technologies, Inc. (USAT), and Vivint Solar, Inc. (VSLR).

Watch video here.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.